Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 249
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #225: Q1 Lobbying Update; Individual vs. Group MDMA Therapy Study Launches; Australia Loosens Psychedelics Access Regulations; VA Launches “New” MDMA Trial
Three Brain Injuries, One Iboga Protocol, and What It Tells Us
The War on Drugs Was Never About Drugs. Psychedelic Healing Must Reckon With That.
A Dispatch from APA’s Annual Meeting: Psychedelics Return at an Awkward Moment for American Psychiatry
Momentum Amidst Tumult: The FDA Reshuffle, Approval Timelines, and the Compass-Usona Race
Wesana Health Announces Definitive Agreement to Acquire PsyTech Inc.
Red Light Holland Sells Approximately 350,000 Grams of Magic Truffles and...
Cybin Files its 13th Patent Application and Announces Digital Therapeutics Strategy
Mydecine Innovations Group Announces Launch of Mindleap Version 2.0
Lobe Sciences Appoints Gilberto Jesús Mendoza, President of the World Boxing...
PT253 – Sean Hinton Ph.D. – Culture, Research Limitations, and Non-Medical...
MINDCURE Announces Filing of U.S. Provisional Patent Applications for Company’s First...
Dissociation as Medicine? Exploring Dissociation & Dissociative Psychedelics like Ketamine
Numinus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for...
Psychedelic Bulletin: Compass Announces New Collaboration; MindMed Partners with Real-World Data...
Load more